10.03.2014 - In response to an application by U.S. drugmaker Eli Lilly for approval of a New Drug Application (NDA) for its type 2 diabetes treatment empagliflozin, the U.S. Food and Drug...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)